Valuation: DocMorris AG

Market Cap 518M 631M 555M 475M 889M 60.46B 911M 6.14B 2.4B 29.92B 2.37B 2.32B 103B P/E 2026 *
-6.76x
P/E 2027 * -13.5x
Enterprise Value 718M 875M 769M 659M 1.23B 83.83B 1.26B 8.51B 3.33B 41.48B 3.29B 3.21B 143B EV / Sales 2026 *
0.58x
EV / Sales 2027 * 0.54x
Free-Float
66.45%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 2022-04-27
Director of Finance/CFO 56 2024-09-30
Chief Tech/Sci/R&D Officer - 2024-10-31
Director TitleAgeSince
Chairman 68 2022-04-27
Director/Board Member 53 2019-05-22
Director/Board Member 56 2020-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 640M
-1.30%+5.87%-21.00%-29.48% 15.44B
-0.28%+4.96%-27.42%-34.78% 7.07B
-3.08%+7.00%-16.03%-5.69% 6.22B
+1.02%+4.32%-4.82%-29.25% 4.02B
+0.74%+3.72%-27.32%-46.50% 3.26B
+0.74%+1.17%+9.08%-32.36% 3.17B
0.00%-1.35%-41.74%-23.50% 3.04B
+2.65%+7.10%-9.89%+5.73% 2.66B
-2.08%+3.07%+101.62% - 2.65B
Average -0.03%+2.17%-4.17%-24.48% 5.28B
Weighted average by Cap. -0.36%+0.89%-12.22%-25.94%

Financials

2026 *2027 *
Net sales 1.24B 1.51B 1.33B 1.14B 2.12B 144B 2.18B 14.67B 5.74B 71.47B 5.66B 5.54B 247B 1.39B 1.69B 1.49B 1.27B 2.39B 162B 2.44B 16.47B 6.44B 80.26B 6.36B 6.22B 277B
Net income -81.01M -98.77M -86.79M -74.34M -139M -9.46B -143M -961M -376M -4.68B -371M -363M -16.18B -43.68M -53.25M -46.79M -40.08M -75.03M -5.1B -76.88M -518M -203M -2.52B -200M -196M -8.73B
Net Debt 200M 244M 214M 184M 344M 23.37B 352M 2.37B 928M 11.56B 916M 896M 39.97B 236M 288M 253M 217M 405M 27.56B 415M 2.8B 1.09B 13.64B 1.08B 1.06B 47.14B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
10.59CHF
Average target price
10.22CHF
Spread / Average Target
-3.51%

Quarterly revenue - Rate of surprise